Related Experiment Video
Updated: Jun 28, 2026
09:01
Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models
Published on: January 27, 2023
Treatment of vascular calcification
1Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA. woneill@emory.edu
Kidney International
|November 15, 2008
Summary
Sodium thiosulfate effectively prevents medial vascular calcification in rats with kidney failure. Further research is needed to understand its mechanism and ensure safety for human use.
Area of Science:
- Cardiovascular Research
- Nephrology
- Pharmacology
Background:
- Vascular calcification is a significant complication in chronic kidney disease.
- Existing therapies for vascular calcification often lack rigorous scientific validation.
- Potential treatments are explored based on biological mechanisms, chemical properties, or empirical patient data.
Discussion:
- Pasch et al. demonstrated that sodium thiosulfate inhibits medial vascular calcification in a rat model of uremia.
- This study provides a scientific rationale for investigating sodium thiosulfate as a therapeutic agent.
- The precise mechanism by which sodium thiosulfate exerts its protective effect remains to be fully elucidated.
Key Insights:
- Sodium thiosulfate shows promise in preventing vascular calcification.
- The study utilized a uremic rat model to assess therapeutic efficacy.
- Convincing evidence supports the anti-calcification properties of sodium thiosulfate in this model.
Outlook:
- Further investigation into the mechanism of action of sodium thiosulfate is warranted.
- Clinical trials are necessary to evaluate the safety and efficacy of sodium thiosulfate in human patients.
- Understanding potential side effects and long-term safety profiles is crucial for clinical translation.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...